Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis

BACKGROUND: To estimate the efficacy of neoadjuvant chemotherapy (NCT) in stage T3-4N1 nasopharyngeal carcinoma (NPC). METHODS: Data on stage T3-4N1 NPC patients treated with concurrent chemoradiotherapy (CCRT) with or without NCT at the Sun Yat-sen University Cancer Center between January 2006 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Wu, Zheng, Xie, Dehuan, Lv, Shaowen, Xia, Liangping, Su, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331182/
https://www.ncbi.nlm.nih.gov/pubmed/32615984
http://dx.doi.org/10.1186/s13014-020-01594-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331182/
https://www.ncbi.nlm.nih.gov/pubmed/32615984
http://dx.doi.org/10.1186/s13014-020-01594-4

Ejemplares similares